CME Group Inc.

NasdaqGS:CME Stock Report

Market Cap: US$83.8b

CME Group Future Growth

Future criteria checks 1/6

CME Group is forecast to grow earnings and revenue by 3.2% and 3.5% per annum respectively. EPS is expected to grow by 3.6% per annum. Return on equity is forecast to be 14.2% in 3 years.

Key information

3.2%

Earnings growth rate

3.6%

EPS growth rate

Capital Markets earnings growth12.1%
Revenue growth rate3.5%
Future return on equity14.2%
Analyst coverage

Good

Last updated27 Jan 2025

Recent future growth updates

Analysts Are Updating Their CME Group Inc. (NASDAQ:CME) Estimates After Its First-Quarter Results

Apr 26
Analysts Are Updating Their CME Group Inc. (NASDAQ:CME) Estimates After Its First-Quarter Results

Recent updates

CME Group: Exchanges And Data Will Keep Growing, And So Could Its Dividend

Dec 30

CME Group's Dominance Challenged By Now Operational FMX?

Dec 13

CME Group: 5 Reasons Why I Am Bullish

Nov 24

Trade On, Cash In: Why CME Group Is My Pick For Income And Growth

Oct 27

Do CME Group's (NASDAQ:CME) Earnings Warrant Your Attention?

Oct 23
Do CME Group's (NASDAQ:CME) Earnings Warrant Your Attention?

CME Group: An Attractive Business Relatively Out Of Favor

Oct 15

CME Group: An Interesting Option For Every Dividend Investor

Oct 08

CME Group: Poised To Benefit From Rate Cuts; Continues To Innovate

Sep 03

CME Group Has It All - Growth, Dividend Growth, And Value

Aug 26

Down But Not Out: Why CME Group Remains One Of My Favorite Dividend Stocks

Aug 01

CME Group Inc.'s (NASDAQ:CME) Price Is Out Of Tune With Earnings

Jul 02
CME Group Inc.'s (NASDAQ:CME) Price Is Out Of Tune With Earnings

CME Group: FMX Market Entry Poses Real Risk

Jul 01

CME Group (NASDAQ:CME) Will Pay A Dividend Of $1.15

Jun 05
CME Group (NASDAQ:CME) Will Pay A Dividend Of $1.15

Looking For (Special) Dividends? CME Group Remains One Of My Best Ideas In Finance

May 25

CME Group (NASDAQ:CME) Will Pay A Dividend Of $1.15

May 21
CME Group (NASDAQ:CME) Will Pay A Dividend Of $1.15

Gunning For CME's Golden Goose

May 01

Analysts Are Updating Their CME Group Inc. (NASDAQ:CME) Estimates After Its First-Quarter Results

Apr 26
Analysts Are Updating Their CME Group Inc. (NASDAQ:CME) Estimates After Its First-Quarter Results

CME Group: Appealing Business Characteristics That Could Benefit From Geopolitical Uncertainty

Apr 15

CME Group: Improved Valuation Offset By Low Market Volatility And Higher Rates

Mar 27

CME Group (NASDAQ:CME) Will Pay A Dividend Of $1.15

Mar 05
CME Group (NASDAQ:CME) Will Pay A Dividend Of $1.15

CME Group Is One Of My Favorite High-Yielding Stocks Today

Feb 29

CME Group (NASDAQ:CME) Has Announced A Dividend Of $1.15

Feb 20
CME Group (NASDAQ:CME) Has Announced A Dividend Of $1.15

CME Group: Buying 'The House' Proves A Winning Strategy

Feb 14

CME Group: Uncertainty In The World Equals Higher Revenue Growth

Feb 04

Earnings and Revenue Growth Forecasts

NasdaqGS:CME - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20276,7473,7424,2654,5653
12/31/20266,5523,6914,0704,29513
12/31/20256,2573,5213,9134,08214
12/31/20246,1023,4573,7823,98015
9/30/20246,0343,4223,6283,717N/A
6/30/20245,7883,2623,4923,571N/A
3/31/20245,6163,1573,3633,444N/A
12/31/20235,5693,1863,3773,454N/A
9/30/20235,3383,0113,3113,391N/A
6/30/20235,2282,9423,1083,192N/A
3/31/20235,1042,8283,0783,159N/A
12/31/20225,0092,6572,9663,056N/A
9/30/20224,8332,6332,6502,743N/A
6/30/20224,7152,8892,6162,717N/A
3/31/20224,6572,7452,4772,599N/A
12/31/20214,6902,6172,2752,402N/A
9/30/20214,6302,4352,2252,394N/A
6/30/20214,6001,9201,8882,074N/A
3/31/20214,6031,9132,3782,561N/A
12/31/20204,8842,1052,5182,716N/A
9/30/20204,9112,1512,5812,775N/A
6/30/20205,1092,3753,0713,274N/A
3/31/20205,2002,3862,5212,761N/A
12/31/20194,8682,1172,4272,673N/A
9/30/20194,9592,0332,2292,464N/A
6/30/20194,5881,8082,0272,236N/A
3/31/20194,3771,8602,1372,285N/A
12/31/20184,3091,9622,3242,441N/A
9/30/20183,9734,5162,3012,391N/A
6/30/20183,9594,413N/A2,316N/A
3/31/20183,8244,262N/A2,057N/A
12/31/20173,6454,063N/A1,751N/A
9/30/20173,6581,498N/A1,801N/A
6/30/20173,6091,662N/A1,773N/A
3/31/20173,5901,566N/A1,732N/A
12/31/20163,5951,534N/A1,732N/A
9/30/20163,4961,452N/A1,607N/A
6/30/20163,5051,340N/A1,591N/A
3/31/20163,4181,284N/A1,626N/A
12/31/20153,3271,247N/A1,533N/A
9/30/20153,3541,262N/A1,644N/A
6/30/20153,2661,192N/A1,414N/A
3/31/20153,1781,191N/A1,327N/A
12/31/20143,1131,127N/A1,291N/A
9/30/20142,9581,014N/A1,171N/A
6/30/20142,911960N/A1,066N/A
3/31/20142,9901,008N/A1,268N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: CME's forecast earnings growth (3.2% per year) is above the savings rate (2.6%).

Earnings vs Market: CME's earnings (3.2% per year) are forecast to grow slower than the US market (15.1% per year).

High Growth Earnings: CME's earnings are forecast to grow, but not significantly.

Revenue vs Market: CME's revenue (3.5% per year) is forecast to grow slower than the US market (8.9% per year).

High Growth Revenue: CME's revenue (3.5% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: CME's Return on Equity is forecast to be low in 3 years time (14.2%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/30 12:39
End of Day Share Price 2025/01/30 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

CME Group Inc. is covered by 39 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Stephen BiggarArgus Research Company
Roger FreemanBarclays
Benjamin BudishBarclays